Literature DB >> 3207960

Aesthetic considerations related to repair of the bilateral cleft lip nasal deformity.

R W Pigott1.   

Abstract

A study of the changing configuration of the nose tip with age shows that the columella naturally takes a greater share of nose tip projection with increasing age. In the infant and small child, when most repairs are done, nose tip projection is due more to the alar dome component than to the columella. Over-lengthening the columella at the expense of alar dome projection results in an unaesthetic nose at maturity. The nasal correction should be towards a normal proportion for age and attention must be paid to alar dome configuration. Where the inferior view shows a "tent tip" skyline, lateral crus advancement is required and can be achieved in asynchronous repairs by Pigott alar leapfrog at primary repair or by Potter V-Y advancement at the time of forked flap columella lengthening. The profile view of the nose and lip shows that the lip "drops" from a point about two-thirds of the way from nostril apex to alar base. A key stitch advancing the alar bases at the time of columella lengthening allows the philtral area to bow forwards as a prow so that it comes to lie in a normal relationship with the columella in the profile view.

Entities:  

Mesh:

Year:  1988        PMID: 3207960     DOI: 10.1016/0007-1226(88)90167-1

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  3 in total

1.  [Outcome of Van der Meulen columellar extension in bilateral lip-jaw-palate clefts].

Authors:  C Mohr
Journal:  Mund Kiefer Gesichtschir       Date:  1997-09

Review 2.  Embryonic rationale for the primary correction of classical congenital clefts of the lip and palate.

Authors:  D R Millard
Journal:  Ann R Coll Surg Engl       Date:  1994-05       Impact factor: 1.891

3.  Secondary bilateral cleft lip-nose deformity correction by rhinoplasty with simultaneous Abbe flap.

Authors:  Nitin J Mokal; Manpreet Juneja
Journal:  Indian J Plast Surg       Date:  2014-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.